{"result": "(\"entity\"<|>NEOPLASIAS DE CABEZA Y CUELLO<|>EVENT<|>Neoplasias de cabeza y cuello refer to cancers located in the head and neck region, which require specific nutritional approaches during treatment.)\n##\n(\"entity\"<|>FORMULAS INMUNOMODULADORAS<|>EVENT<|>Formulas inmunomoduladoras are specialized nutritional formulas that contain amino acids, nucleotides, and other components aimed at improving the nutritional status of patients with head and neck cancers.)\n##\n(\"entity\"<|>HOSPITALIZACIÓN<|>EVENT<|>Hospitalización refers to the period a patient spends in the hospital, which can be influenced by nutritional status and complications from surgery.)\n##\n(\"entity\"<|>FISTULAS<|>EVENT<|>Fístulas are abnormal connections that can occur post-surgery, which may be reduced by proper nutritional support.)\n##\n(\"entity\"<|>DEHISCENCIA DE SUTURA<|>EVENT<|>Dehiscencia de sutura refers to the reopening of a surgical wound, which can be influenced by the patient's nutritional state.)\n##\n(\"entity\"<|>ALIMENTACIÓN ORAL<|>EVENT<|>Alimentación oral refers to the ability of a patient to eat by mouth, which is a key aspect of recovery after treatment.)\n##\n(\"relationship\"<|>PACIENTE<|>NEOPLASIAS DE CABEZA Y CUELLO<|>The patient is being treated for neoplasias de cabeza y cuello, which impacts their nutritional needs<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>FORMULAS INMUNOMODULADORAS<|>The patient is receiving formulas inmunomoduladoras to improve their nutritional status during treatment<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>HOSPITALIZACIÓN<|>The patient's nutritional status can affect their length of hospitalization<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>FISTULAS<|>Proper nutritional support may help reduce the risk of fistulas in the patient<|>5)\n##\n(\"relationship\"<|>PACIENTE<|>DEHISCENCIA DE SUTURA<|>The patient's nutritional state can influence the risk of dehiscencia de sutura post-surgery<|>5)\n##\n(\"relationship\"<|>PACIENTE<|>ALIMENTACIÓN ORAL<|>The patient is working towards regaining the ability for alimentación oral after treatment<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ula, siendo las fórmulas estándar y poliméricas las más aceptadas. Si se prevé que esta NE va a durar más de 4 semanas se debe indicar la gastrostomía².\n\nUn especial interés en las neoplasias de ORL lo abarca las fórmulas inmunomoduladoras: fórmulas de NE o SNO que contienen aminoácidos, nucleótidos, ácidos grasos omega 3, arginina y glutamina. En algunos estudios, han demostrado que en cabeza y cuello pueden mejorar el estado nutricional y sobretodo disminuir las complicaciones postquirúrgicas de la herida como la infección o dehiscencia de sutura, así como la estancia hospitalaria⁸. De hecho, la guía ESPEN de Nutrición en el Paciente Oncológico, incluye las neoplasias de cabeza y cuello dentro de las que se benefician de las fórmulas inmunomoduladoras, previo y posterior a la intervención quirúrgica independientemente de su estado nutricional⁶. Específicamente en cabeza y cuello, la arginina, en un metaanálisis⁹, también ha demostrado que si se recibe peri/postoperatoriamente en NE reduce el número de fístulas y estancia hospitalaria, con influencia neutra en cuanto a infección de la herida quirúrgica. En otros estudios¹⁰, sin ser su objetivo principal, también se vio que administrada perioperatoriamente proporcionaba mayor supervivencia a largo plazo y tiempo sin recurrencia, aunque estudios más firmes son necesarios para confirmar estas premisas.\n\nLa pauta de inmunonutrición que ha demostrado ser más costo efectiva y publicada en la literatura es¹¹:\n\n- Predilección por la vía oral.\n- Administrarla 5-7 días previo a la cirugía y 7 días después.\n- En forma de SNO: 3 al día de 250 ml y en forma de NE: 1000-1500 ml diarios.\n\nAl paciente del caso clínico se solicitó la colocación de una GRP profiláctica, pero dado que no se contactó con la UN previo a la LT, sólo se pudo beneficiar de la inmunonutrición en el periodo post-quirúrgico, 7 días después de la cirugía. Además, es un paciente con DM tipo 2 en tratamiento con insulina, que también requiere un abordaje específico dentro de las fórmulas de NE.\n---\nCada vez con mayor evidencia y respaldo se sostiene que las fórmulas para DM pueden mejorar el control glucémico a corto y largo plazo, a través de un menor incremento de la glucemia post-prandial, de menores requerimientos de insulina y en algunos casos, en mejoría de la hemoglobina glicosilada e incluso variabilidad glucémica e hipoglucemias¹². Estas fórmulas, se caracterizan por aportar:\n\n- Hidratos de carbono de bajo índice glucémico (almidón, fructosa, maltodextrinas).\n- Ácidos grasos monoinsturados en mayores proporciones que el resto de fórmulas.\n- Alta proporción de fibra soluble (puede mejorar el perfil lipídico y glucémico).\n- Micronutrientes antioxiantes.\n\nEn nuestro caso, tras pasar el periodo de la inmunonutrición de los 7 días, donde es costo-efectiva, el paciente estuvo con NE con fórmula para DM, por los beneficios que le puede aportar.\n\nOtro aspecto clave en este espectro de pacientes, es el soporte nutricional y seguimiento cuando se va a recibir RT y/o QT. Asociado ambas terapéuticas a mucositis y en lo que ello repercute, disfagia y afagia, se aconseja casi un seguimiento semanal para el soporte nutricional y prevenir la pérdida de peso, la monitorización de la ingesta e impedir así la interrupción de los tratamientos. Es tan importante este seguimiento que se aconseja visitar al paciente y supervisar mínimo hasta 3 meses tras el tratamiento².\n\nPor último, no hay ninguna directriz marcada con respecto a cuando retirar la GRP/PEG. El paciente del caso clínico recuperó totalmente la ingesta oral hasta alcanzar requerimientos calóricos, además de corroborar que no iba a recibir ningún tratamiento más que pudiese empeorar su estado nutricional. Una vez se retiró la GRP, fue y es necesario mantener un seguimiento dietético y nutricional, pudiendo dilatarlo más en el tiempo si el paciente está estable, para comprobar que se recupera la deglución y la vía oral.\n\n## Conclusión\n\nLa patología oncológica de cabeza y cuello requiere de un importante abordaje nutricional previo, durante y posterior al tratamiento, sea cual sea, desde cirugía, QT y/o RT; por la repercusión que puede tener sobre la vía oral. En pacientes en los que se va a prevenir una baja ingesta oral\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ESPEN<|>ORGANIZATION<|>ESPEN is the European Society for Clinical Nutrition and Metabolism, which provides guidelines for nutrition in oncology patients.)\n##\n(\"entity\"<|>GRP<|>ORGANIZATION<|>GRP refers to Gastrostomy Replacement Procedure, a method used for nutritional support in patients unable to eat orally.)\n##\n(\"entity\"<|>DM<|>ORGANIZATION<|>DM refers to Diabetes Mellitus, a condition that requires specific nutritional formulas to manage blood glucose levels.)\n##\n(\"entity\"<|>RT<|>EVENT<|>RT refers to Radiotherapy, a treatment that can lead to complications such as mucositis in head and neck cancer patients.)\n##\n(\"entity\"<|>QT<|>EVENT<|>QT refers to Chemotherapy, another treatment that can affect the nutritional status of head and neck cancer patients.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>NUTRICIÓN refers to the nutritional support and management required for patients undergoing treatment for head and neck cancer.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>PACIENTE refers to the patient in the clinical case who underwent nutritional support and treatment for head and neck cancer.)\n##\n(\"relationship\"<|>PACIENTE<|>GRP<|>The patient underwent a Gastrostomy Replacement Procedure for nutritional support<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>DM<|>The patient has Diabetes Mellitus, which requires specific nutritional management<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>RT<|>The patient is receiving Radiotherapy, which impacts their nutritional needs<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>QT<|>The patient is receiving Chemotherapy, which affects their nutritional status<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN<|>The patient requires nutritional support during and after treatment for head and neck cancer<|>9)\n##\n(\"relationship\"<|>ESPEN<|>NUTRICIÓN<|>ESPEN provides guidelines for nutritional management in oncology patients<|>8)\n##\n(\"relationship\"<|>DM<|>NUTRICIÓN<|>Nutritional formulas for Diabetes Mellitus are designed to improve glycemic control<|>7)\n<|COMPLETE|>"}]}